Premium
Treatment of thyroid cancer based on risk groups
Author(s) -
Shaha Ashok
Publication year - 2006
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.20697
Subject(s) - medicine , thyroid cancer , thyroidectomy , oncology , thyroid , adjuvant therapy , cancer , adjuvant
The understanding of the prognostic factors and risk groups is crucial in the management of well differentiated thyroid cancer. The important prognostic factors are age, grade of tumor, extrathyroidal extension, size of tumor, and distant metastases. Based on these prognostic factors, patients can be divided into low‐, intermediate‐, and high‐risk groups. The treatment decisions should be based on risk group analysis. Extent of thyroidectomy and adjuvant therapy can be based on the risk group analysis. The histopathologic studies are very important to distinguish well differentiated from the tall cell, insular, and poorly differentiated thyroid cancer. J. Surg. Oncol. 2006;94:683–691. © 2006 Wiley‐Liss, Inc.